Daniela Grinis

Ms. Daniela Grinis

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2026 in Cells
Verified
Journal Article
Open access
PDF file
DGDaniela Grinis
Daniela Grinis
MTMarina Thomas
Marina Thomas
CACaroline Aprigliano
Caroline Aprigliano
AMAnish Maskey
Anish Maskey
Keloids and hypertrophic scars are fibroproliferative disorders of wound healing characterized by excessive extracellular matrix deposition, constant inflammation, and high recurrence rates despite appropriate management. Conventional therapies, including surgical excision, corticosteroid injections, laser therapy, and radiation, can provide temporary relief. However, treatment failure remains common, specifically in refractory keloids. Recent findings suggest these outcomes cannot be fully explained by technical or mechanical factors alone, and pathological scarring may reflect underlying immune and neuroimmune dysfunction. Current evidence shows prolonged activation of pro-inflammatory and pro-fibrotic cytokine pathways like IL-6, TNF-α, TGF-β, and IL-17 drives sustain fibroblast activation and disrupts normal wound healing and remodeling. Additionally, the skin functions as an integrated neuro-endocrine-immune organ, allowing bidirectional communication between cutaneous nerves, immune cells, and stromal tissue. Neurogenic inflammation is mediated by neuropeptides, mast cell activation, and stress-induced hypothalamic–pituitary–adrenal axis dysregulation, which further amplifies inflammation within scar tissue. Psychiatric comorbidities like depression, anxiety, and chronic psychological stress serve as a positive feedback mechanism and are increasingly recognized as biologically active contributors to immune dysregulation. This review highlights critical gaps in current management strategies and emphasizes the need for biologically informed, multidisciplinary approaches to improve long-term outcomes for keloid and hypertrophic scar management.

18 November 2026 in Cancers
Verified
Journal Article
Open access
PDF file
DGDaniela Grinis
Daniela Grinis
DADrew Alessi
Drew Alessi
MEMichelle Elway
Michelle Elway
AMAnish Maskey
Anish Maskey
Cutaneous malignancies develop inside immune microenvironments composed of tumor cells, fibroblasts, vasculature, cytokines, and extracellular matrix components. These molecules control cell growth, escape from the immune system, development of blood vessels, and tissue invasion, and are also involved in biological reactions necessary for wound healing. After surgical excision, the local tissue environment needs to change from a chronically regulated tumor microenvironment to an acute response mechanism for repair of the wound. However, constant inflammatory, stromal, vascular, and immune alterations can disrupt this tumor-to-wound transition and contribute to delayed healing and reconstructive complications. This narrative review examines the immune microenvironments of basal cell carcinoma, cutaneous squamous cell carcinoma, and melanoma and evaluates how their distinct immunologic and stromal characteristics may influence postoperative wound healing and surgical reconstruction. This study also examines the interconnected functions of macrophages, neutrophils, natural killer cells, dendritic cells, T-lymphocytes, regulatory T-cells, cytokines, fibroblasts, and extracellular matrix remodeling in tumor biology and tissue regeneration. Patient- and treatment-related factors, including advanced age, diabetes mellitus, tobacco use, obesity, immunosuppression, prior radiation, and systemic anticancer therapy, may further modify the postoperative wound environment. While there is insufficient direct evidence to make any links between the biological transition of immune cells preoperatively and reconstruction results, gaining knowledge about this biological transition can allow identification of those patients who are at high risk for developing an infection or wound dehiscence. Future studies integrating tumor immune profiling with postoperative outcomes can support the development of immune-informed, individualized reconstructive strategies following skin cancer excision.